First shipment of HIV‑prevention drug Lenacapavir arrives in South Africa
The United States sent the initial batch of the long‑acting injectable Lenacapavir to South Africa in early April 2026, ahead of a planned rollout beginning in June.
The first shipment of Lenacapavir arrived in South Africa from the United States in early April 2026. Lenacapavir is a long‑acting injectable that prevents HIV with two shots a year. Clinical trials showed near‑complete protection of more than 99% against HIV.
The rollout of the drug is expected to begin in June 2026. The program will prioritize adolescent girls and young women, pregnant and breastfeeding women, transgender people, sex workers, men who have sex with men, and people who inject drugs.
France24 reported that mass rollout campaigns are planned across Southern Africa, including South Africa, Zambia, Eswatini, Zimbabwe, Lesotho and Mozambique. The outlet also reported that Lenacapavir has been approved for preventive treatment.
This account was written only from facts that survived Augur's
corroboration pass — 5 corroborated across opposed news blocs,
0 contested (attributed to both sides), 2
single-source (attributed). Nothing was added; no significance was inferred.
Model Qwen3-Next-80B-A3B-Instruct.
See the evidence & the verbatim quotes →